On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayOct 23, 2020 8:30 am

NetworkNewsAudio – 180 Life Sciences Corp. Founders Leverage History of Success Developing, Selling New Drugs to Big Pharma

Related Editorial Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally is a new drug developed that’s approved and generates more than $1 billion per year in sales, a benchmark in the industry commonly called a “blockbuster.” Blockbusters are scarce, but the proverbial quest for blockbuster drugs continues unabated because of vast unmet medical needs and because blockbuster therapeutics can be worth tens of billions of dollars during their patent-protected lives. Little wonder that pharmaceutical giants often buy up promising…

Continue Reading

FridayOct 16, 2020 8:30 am

NetworkNewsAudio – KBL Merger Corp. IV (NASDAQ: KBLM) Identifies 180 Life Sciences Corp. as Perfect Target; Companies Set to Merge

Related Editorial The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a blank-check company formed to raise capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have evolved to become an expedited and cost-effective way of doing an M&A deal and have been utilized by multiple Wall Street heavyweights. Going public via a SPAC enables a company to get a deal done in weeks instead of months,…

Continue Reading

FridayOct 16, 2020 8:30 am

NetworkNewsAudio – Cybin Corp. Targeting Underserved Mental Illnesses with Drugs Derived from Psychedelics

Related Editorial Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as "magic mushrooms." There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as Cybin…

Continue Reading

TuesdayOct 06, 2020 8:30 am

NetworkNewsAudio – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Interview

Founded in 2012, The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new…

Continue Reading

MondayOct 05, 2020 8:30 am

NetworkNewsAudio – 180 Life Sciences Corp. Dedicated to Developing Groundbreaking Anti-Inflammatory Drugs

Related Editorial Inflammation typically occurs in the body as a natural response to threats such as infection or injury, but chronic inflammation can cause severe damage and even death. Inflammation is a well-known symptom of multiple infectious diseases. However, multidiscipline research strongly suggests that inflammation is also closely linked with a broad range of noninfectious diseases. The critical aspects of the interplay between inflammation and disease may well be the key to development of a new generation of drugs to treat previously untreatable diseases, sparking a flurry of biotech research and development in the field. At the vanguard of this…

Continue Reading

FridayOct 02, 2020 8:30 am

NetworkNewsAudio – Kaival Brands Innovations Group Inc. (KAVL) to Develop Smoking Cessation Products Using Purified, Synthetic Nicotine

Related Editorial Approximately 1,300 people die every day as a result of smoking, and more than 16 million Americans are living with a disease caused by smoking. These alarming numbers aren’t going unnoticed, and companies with expertise in the space are seizing the opportunity to provide solutions designed to help smokers kick the habit. One of those companies, Kaival Brands Innovations Group Inc. (OTCQB: KAVL) (KAVL Profile), has just acquired a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products; the company is also creating a subsidiary that will own the patent and…

Continue Reading

MondaySep 28, 2020 8:30 am

NetworkNewsAudio – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Sees Record Growth as Consumers Crave Healthier Beverage Options

Related Editorial Soda sales over the past 15 years have fallen significantly, leaving major beverage brands looking for alternative ways to expand their portfolios to capture a portion of the various new craft beverages that consumers drink each day. Many of these large companies are opting to go the M&A route, recognizing the significant impact that smaller specialty brands in the space might have on their existing offerings. Companies such as The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) (WTER Profile), one of the fastest-growing enhanced water companies in the industry, could be an attractive option. In the meantime, Keurig Dr.…

Continue Reading

ThursdaySep 24, 2020 8:30 am

NetworkNewsAudio – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Enhances Position in Gold Mining Industry

Related Editorial With government spending skyrocketing and the value of the U.S. dollar sinking, savvy investors are turning to gold, which surpassed $2,000 an ounce in August. Experts predict that the precious metal could go much higher in light of depressed bond yields, inflation fears, and the reverberations of COVID-19 on the global economy. Gold’s 32% rally this year has made it “one of the world’s best-performing mainstream assets,” as reported in a Financial Times article. Given global economic conditions and surging demand, savvy mining resource companies are making strategic moves to leverage their expertise and position themselves to reap…

Continue Reading

FridaySep 18, 2020 8:30 am

NetworkNewsAudio – Kaival Brands Innovations Group Inc. (KAVL) Securing Substantial Market Share in Flourishing Vape Sector

Related Editorial With the global e-cigarette and vape market expected to exceed $59 billion by 2027, the vaping industry appears to have weathered a cloud of scrutiny and is emerging better regulated and even stronger. Much of that growth stems from an increasing awareness of the advantages of consuming smokeless and ashless nicotine, backed up with growing studies. Although larger tobacco companies control a large share of the global e-cigarette and vape market, smaller elite players such as Kaival Brands Innovations Group Inc. (OTCQB: KAVL) (KAVL Profile) are making their presence felt in a space where innovation and compliance are essential…

Continue Reading

TuesdaySep 15, 2020 8:30 am

NetworkNewsAudio – Cybin Corp. Interview

Cybin Corp. is a mushroom life-science company advancing psychedelic and nutraceutical-based products. The company expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited. Simultaneously, the company is structuring and supporting clinical studies across North America and other regions through strategic academic and institutional partnerships. For more information, visit the company's website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to Cybin are available in the company’s newsroom at http://nnw.fm/Cybin About NetworkNewsAudio NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217